Should ChemoCentryx Be in Your Portfolio?

Biotech and pharmaceutical stocks have come to the forefront due to the pandemic. ChemoCentryx (CCXI) aims to provide therapies to combat cancer, autoimmune diseases, and inflammatory disorders, but is it a buy? Read more to find out.

Leave a Reply

Your email address will not be published. Required fields are marked *